Zyprexa Injury Claims Time Barred, 2nd Circuit Affirms



DOCUMENTS
  • Summary Order


NEW YORK — A product liability suit filed against Eli Lilly & Co. (NYSE: LLY) in connection with Zyprexa is barred by Virginia’s two-year statute of limitations because the plaintiff’s injuries were diagnosed more than three years before he filed his action, a federal appeals court has affirmed.

On Dec. 10, the 2nd Circuit U.S. Court of Appeals ruled that even if the drug maker intentionally concealed the discovery of the plaintiff’s claims, his action is still time-barred because he could have reasonably discovered the cause of his alleged injuries and filed suit as early as 2001 and no later …

FIRM NAMES
  • Pepper Hamilton
  • Richardson Richardson Boudreaux Keesling





UPCOMING CONFERENCES




HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel

MORE DETAILS